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Abstract: Zinc chloride is a source of zinc used in various pharmaceutical/nutraceutical formulations. The objective of the 
current study was to investigate the impact of The Trivedi Effect® - Energy of Consciousness Healing Treatment (Biofield 
Energy Treatment) on physical, structural, thermal, and behavioral properties of zinc chloride using PXRD, PSD, FT-IR, UV-
vis, and DSC analysis. Zinc chloride was divided into two parts – one part was control, while another part was treated with The 
Trivedi Effect® remotely by twenty renowned Biofield Energy Healers and defined as The Trivedi Effect® Treated sample. A 
significant alteration of the crystallite size and relative intensities of the PXRD peaks was observed in The Trivedi Effect® 
treated sample compared with the control sample. The average crystallite size of the treated sample was significantly increased 
by 23.18% compared with the control sample. The particle size values at d10, d50, and d90 values were significantly decreased 
by 3.70%, 4.13%, and 6.13%, respectively in the treated sample compared with the control sample. Therefore, the surface area 
of the treated sample was increased by 4.21% compared with the control sample. The FT-IR spectroscopic analysis revealed 
that Zn-Cl stretching in the control sample was found at 512 cm-1, whereas it was significantly shifted upward to 520 cm-1 in 
the treated sample. The UV-vis analysis exhibited that wavelength of the maximum absorbance (λmax) of the control and treated 
samples were at 197.6 nm and 197.1 nm, respectively. The DSC analysis exhibited that the melting temperature was decreased 
by 0.22%, while decomposition temperature was increased by 2.56% in the treated sample compared to the control sample. 
The latent heat of fusion of the treated sample (320.44 J/g) was significantly decreased by 16.70% compared with the control 
sample (284.67 J/g). Similarly, the enthalpy of decomposition of the treated sample (952.53 J/g) was significantly increased by 
122.61% compared with the control sample (427.90 J/g). Thus, the results indicated that the thermal stability of the treated zinc 
chloride was improved compared with the control sample. The current study anticipated that The Trivedi Effect® - Energy of 
Consciousness Healing Treatment might lead to produce a thermally stable new polymorphic form of zinc chloride, which 
would be more soluble and bioavailable compared with the untreated compound. Hence, the treated zinc chloride would be 
very useful to design better nutraceutical/pharmaceutical formulations that might offer better therapeutic response against 
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inflammatory diseases, immunological disorders, aging, stress, cancer, etc.  
Keywords: Zinc Chloride, Consciousness Energy Healing Treatment, Biofield Energy Healers, The Trivedi Effect®, PXRD, 
Particle Size, Surface Area, DSC 
 
1. Introduction 
Zinc is an essential element in human body due to its broad 
spectrum of physiological functions. It plays an important role 
in catalytic, structural or regulation in enzymes in the body, 
which involved in the nucleic acid and protein metabolism as 
well as for the production of energy. Zinc also maintains the 
structural integrity of the biological membranes resulting in 
their protection against oxidative injury [1-2]. As a 
metallotherapeutic agent, zinc possesses various 
pharmacological activities include fertility enhancing, retino-
protective, and putative antiviral activities [3]. Zinc is also 
used in the treatment of Wilson’s disease [4]. It has also 
immunomodulatory and antioxidant activities [1]. Zinc is also 
used to prevent the development of several deficiency 
symptoms include parakeratosis, hypogeusia, anorexia, 
dysosmia, geophagia, hypogonadism, growth retardation, etc. 
[5-7]. Recently, it has been reported that zinc had increased the 
leukocyte count and phagocytic index, which potentiate the 
immunomodulatory effect along with Glycyrrhiza glabra [8]. 
Zinc chloride (ZnCl2) is hygroscopic inorganic salt and highly 
soluble in water [9]. It is used in pharmaceutical industry as 
drug and diagnostic agent due to its powerful astringent and 
mild antiseptic properties [10]. It is also used in mouth-wash 
and deodorant preparations. Zinc chloride is used as dentin 
desensitizer i.e. reduces the sensitivity of the teeth to heat and 
cold. The other applications of zinc chloride include protein 
precipitation and insulin preparation [10, 11]. Literature 
reported that zinc chloride has also been used in the treatment 
of cancer as a destructive agent [12] and in the pluripotency 
maintenance of mouse embryonic stem cell through the 
regulation of STAT3 signaling pathway [13]. It can be used for 
the palliative treatment of canine and malignant skin wounds 
[14]. It has the opposite effect on locomotor behavior of rats 
[15]. Therefore, zinc chloride was considered as one of the 
components in the novel proprietary herbomineral formulation 
for the source of zinc ion. This herbomineral formulation is 
designed as nutraceutical supplement and can be used for the 
prevention and treatment of various human disorders.  
An élan vital or vital force which contributes the ‘life’ is 
preserved by every living organisms and known as prana by 
the Hindus, qi or chi by the Chinese, and ki by the Japanese. 
This is believed to co-relate with the soul, spirit and mind. This 
hypothetical vital force is considered as the Biofield Energy. 
The Biofield Energy is infinite, paradimensional and dynamic 
electromagnetic field surrounding the human body. It can 
freely flow between the human and environment that leads to 
the continuous movement or matter of energy [16, 17]. Thus, a 
human has the ability to harness energy from the earth, the 
“universal energy field” and transmit it to any living or 
nonliving object(s) around the globe. The objects always 
receive the energy and respond in a useful way. This process is 
known as Biofield Energy Healing Treatment [18, 19]. 
Biofield (Putative Energy Fields) based Energy Therapies are 
used worldwide to promote health and healing. The National 
Center of Complementary and Integrative Health (NCCIH) has 
been recognized and accepted Biofield Energy Healing as a 
Complementary and Alternative Medicine (CAM) health care 
approach in addition to other therapies, medicines and 
practices such as natural products, deep breathing, yoga, Tai 
Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, movement 
therapy, pilates, rolfing structural integration, mindfulness, 
Ayurvedic medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial sacral 
therapy and applied prayer (as is common in all religions, like 
Christianity, Hinduism, Buddhism and Judaism) [20]. Biofield 
Energy Treatment (The Trivedi Effect®) has been reported in 
numerous peer-reviewed science journals with significant 
outcomes in many scientific fields such as cancer research 
[21]; altered antimicrobial sensitivity of pathogenic microbes 
in microbiology [22-24], biotechnology [25, 26], genetics [27, 
28]; changing the structure of the atom in relation to various 
metals, ceramics, polymers and chemicals [29, 30], altered 
physical and chemical properties of pharmaceuticals [31, 32], 
nutraceuticals [33, 34], organic compounds [35-37], and 
improved overall growth and yield of plants in agricultural 
science [38, 39]. The physicochemical properties such as 
particle size, crystalline structure, crystallite size, surface area, 
and thermal properties of a drug have a vital role in 
bioavailability as well as stability of the drug during 
processing, formulation, storage, and packaging [40, 41]. The 
particle size, specific surface area, crystalline nature, chemical 
and thermal behavior of an atom/ion might be altered by the 
Biofield Energy Healing Treatment (The Trivedi Effect®) 
through possible mediation of neutrinos [42]. By considering 
all these aspects, powder X-ray diffraction (PXRD), particle 
size distribution analysis (PSD), Fourier transform infrared 
(FT-IR) spectrometry, ultraviolet-visible (UV-vis) 
spectroscopy, and differential scanning calorimetry (DSC) 
analytical techniques were conducted in this study for the 
characterization of physical, structural, and thermal properties 
of the Biofield Energy Treated and untreated zinc chloride. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Zinc chloride was procured from Tokyo Chemical Industry 
Co., Ltd. (TCI), Japan. All other chemicals used in the 
experiment were of analytical grade available in India. 
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2.2. The Trivedi Effect
®
 - Energy of Consciousness Healing 
Treatment Strategies 
Zinc chloride was one of the components of the new 
proprietary herbomineral formulation, developed by our 
research team and it was used per se as the test compound for 
the current study. The test compound was divided into two 
parts, one part of the test compound did not receive any sort 
of treatment and was defined as the untreated or control zinc 
chloride sample. The second part of the test compound was 
treated with The Trivedi Effect® - Energy of Consciousness 
Healing Treatment (Biofield Energy Treatment) by a group 
of twenty renowned Biofield Energy Healers remotely and 
was denoted as Biofield Energy Treated or The Trivedi 
Effect® sample. Thirteen Biofield Energy Healers were 
remotely located in the U.S.A., five were located in Canada, 
and two were located in Australia, while the test compound 
was located in the research laboratory of GVK Biosciences 
Pvt. Ltd., Hyderabad, India. This Biofield Energy Treatment 
was provided for 5 minutes through Healer’s Unique Energy 
Transmission process remotely to the test compound under 
the laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor had 
any contact with the compounds. Similarly, the control 
compound was subjected to “sham” healers for 5 minutes, 
under the same laboratory conditions. The sham healer did 
not have any knowledge about the Biofield Energy 
Treatment. After that, the Biofield Energy Treated and 
untreated samples were kept in similar sealed conditions and 
characterized thoroughly by PXRD, PSD, FT-IR, UV-visible 
spectroscopy, and DSC analysis.  
2.3. Characterization 
2.3.1. Powder X-Ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’Pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the PXRD results, the 
crystallite size (G) was calculated using X’Pert data collector 
and X’Pert high score plus processing software. The 
crystallite size (G) was calculated from the Scherrer equation 
[43, 44]. The method was based on the width of the 
diffraction patterns obtained in the X-ray reflected the 
crystalline region. The crystallite size (G) was calculated by 
using the following formula (1): 
G = kλ/(bCosθ)                               (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peaks and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
following equation 2: 
%	change	in	crystallite	size	 =
		
	
× 100 (2) 
Where, GControl and GTreated are the crystallite size of the 
control and Biofield Energy Treated samples, respectively. 
A total of ~500 mg of the control and Biofield Energy 
Treated samples individually were used for the analysis and 
prepared by back loading technique using the sample 
preparation kit. The sample was spread on the holder ring in 
sufficient quantity to fill the ring cavity. It was then pressed 
down using powder press block and scrap the powder that 
was in surplus using a glass slide to get densely packed 
specimen. Consequently, the bottom plate was placed onto 
the holder ring and clamp in position. The sample holder was 
then removed from the sample preparation table by turning it 
upside down. A smooth surface of sample was obtained to 
ensure optimum results. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with the dispersant medium and operated the 
stirrer at 2500 rpm. Alignment of the optics was done and the 
background measurement was taken. After the background 
measurement, the sample was added into the sample unit 
with constant monitoring the obscuration and stopped the 
addition of sample when the obscuration reached in between 
15% to 20%. When the obscuration was stable, the 
measurement was taken twice and the average of two 
measurements was taken. The average histogram of the two 
measurements was recorded. The data was presented in table 
format which include particle size (µm). Also, the values at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
were calculated from the histogram and the calculations such 
as surface area (m2/g) were done by using software 
Mastersizer 2000. 
Percent change in particle size (d) for at below 10% level 
(d10), 50% level (d50), and 90% level (d90) was calculated 
using following equation 3: 
%	change	in	particle	size =
##
#
× 100      (3) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
of the control and Biofield Energy Treated samples, 
respectively. 
Percent change in surface area (S) was calculated using 
following equation 4: 
%	change	in	surface	area =
&	&	
&	
× 100	   (4) 
Where, SControl and STreated are the surface area of the 
control and Biofield Energy Treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of zinc chloride was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
infrared spectrometer with the frequency array of 400-4000 
cm-1 by using pressed KBr disk technique. 
 American Journal of Bioscience and Bioengineering 2017; 5(2): 65-74  68 
 
2.3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-Vis spectral analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1 cm quartz cell that has a slit width of 
1.0 nm. The wavelength range chosen for recording the 
spectra was 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and wavelength of maximum absorbance 
(λmax) were recorded. 
2.3.5. Differential Scanning Calorimetry (DSC)  
Analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter. A total 
of ~5 mg sample was weighed and sealed in aluminum pans 
and equilibrated at 25°C and heated up to 450°C at the 
heating rate of 10°C/min under nitrogen gas as purge 
atmosphere with flow rate of 50 mL/min. The value for 
onset, endset, peak temperature, peak height (mJ or mW), 
peak area, and change in heat (J/g) for each peak were 
recorded. 
Percent change in the melting/decomposition temperature 
(T) was calculated using following equation 5: 
%	change	in	melting/decomposition	temperature 
++
+
 100                         (5) 
Where, TControl and TTreated are the decomposition temperature of the control and Biofield Energy Treated samples, 
respectively. 
Percent change in the enthalpy of melting/decomposition (∆H) was calculated using following equation 6: 
	%	change	in	latent	heat	of
,-./012
#-34,5460/041

∆898
98
 100                               (6) 
Where, ∆HControl and ∆HTreated are the enthalpy of 
decomposition of the control and Biofield Energy Treated 
samples, respectively. 
3. Results and Discussion 
3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD diffractograms of both the control and Biofield 
Energy Treated zinc chloride are presented in Figure 1. Both the 
samples displayed very sharp and intense peaks in their 
respective diffractogram indicating the crystalline nature of zinc 
chloride. PXRD data such as Bragg angle (2θ), relative intensity 
(%), full width half maximum (FWHM) (θ°), and crystallite size 
(G) for the control and Biofield Energy Treated zinc chloride are 
presented in the Table 1. The crystallite size was calculated with 
the help of Scherrer equation [43, 44]. The crystallite size of the 
control and Biofield Energy Treated samples were found to be 
similar at 2θ equal to nearly 48.6°, 56.2°, and 70.5° (Table 1, 
entry 6, 9, and 13). The crystallite size of the Biofield Energy 
Treated zinc chloride at 2θ equal to nearly 15.6°, 25.4°, 29.3°, 
34.8°, 38.2°, 52.3°, 57.4°, and 72.1° (Table 1, entry 1-5, 8, 10, 
and 14) was significantly increased in the range of 14.28% to 
200.15% compared with the control sample. Consequently, at 2θ 
equal to 49.2°, 58.3°, and 61.8° (Table 1, entry 7, 11, and 12), 
the crystallite size of the Biofield Energy Treated zinc chloride 
was significantly decreased from 24.93% to 49.95% with 
respect to the control sample. However, the average crystallite 
size of the Biofield Energy Treated sample was significantly 
increased by 23.18% (Table 1, entry 15) with respect to the 
control sample. The PXRD diffractogram of the Biofield Energy 
Treated zinc chloride displayed greater intensity at Bragg’s angle 
(2θ) equal to 49.2° (Table 1, entry 7), whereas it was found at 
48.6° (Table 1, entry 6) in the control sample. Beside this, the 
relative intensities of the PXRD peaks (Table 1) in the Biofield 
Energy Treated sample were significantly altered compared with 
the control sample.  
 
Figure 1. PXRD diffractograms of the control and Biofield Energy Treated zinc chloride. 
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Table 1. PXRD data of the control and Biofield Energy Treated zinc chloride. 
Entry  
No. 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated  Control Treated  Control Treated  Control Treated  % change* 
1 15.48 15.61 18.51 85.15 0.1338 0.1171 33.20 37.94 14.28 
2 25.25 25.40 14.52 58.89 0.1673 0.0669 26.97 67.45 150.15 
3 29.18 29.31 35.38 93.23 0.0669 0.0502 68.00 90.65 33.31 
4 34.77 34.80 22.85 28.54 0.1673 0.0816 27.58 56.54 105.04 
5 38.05 38.22 18.11 48.01 0.2007 0.0669 23.21 69.65 200.15 
6 48.50 48.64 68.70 100.00 0.0816 0.0816 59.19 59.22 0.06 
7 49.04 49.20 100.00 64.20 0.0612 0.0816 79.09 59.36 -24.95 
8 51.06 52.26 17.73 24.00 0.0816 0.0612 59.81 80.16 34.01 
9 56.11 56.20 30.24 87.20 0.0816 0.0816 61.17 61.19 0.04 
10 57.18 57.41 15.76 19.63 0.1224 0.0616 40.98 81.53 98.92 
11 58.10 58.28 24.94 25.53 0.1224 0.1632 41.17 30.90 -24.93 
12 61.59 61.78 15.05 18.74 0.102 0.204 50.28 25.16 -49.95 
13 70.30 70.53 30.97 19.55 0.0612 0.0612 88.06 88.19 0.14 
14 71.98 72.12 19.20 25.30 0.1632 0.1224 33.37 44.54 33.45 
15 Average crystallite size 49.43 60.89 23.18 
FWHM: Full width half maximum, *denotes the percentage change in the crystallite size of the Biofield Energy Treated sample with respect to the control 
sample. 
Scientific literature reported that the changes in the XRD 
patterns, such as crystallite size and relative intensities, 
indicated the modification of the morphology of the crystal 
as well as the proof of polymorphic transition [45-47]. As the 
crystal morphology of the Biofield Energy Treated sample 
was altered compared with the control sample, the Biofield 
Energy Treated sample might be a new polymorphic form of 
zinc chloride. The crystal pattern, size and even polymorphic 
form of a pharmaceutical play important roles in drug 
solubility, dissolution and bioavailability. It has been reported 
in the literature that the alteration in crystal morphology has 
significant impact on the in vitro dissolution rate, which is 
related with the bioavailability of orally administered 
pharmaceutical/nutraceutical [41]. So, it can be concluded 
that the Biofield Energy Healing Treatment might be a very 
useful method for enhancing the bioavailability of zinc 
chloride. 
3.2. Particle Size Distribution (PSD) Analysis 
The particle size values (d10, d50, and d90) and the average 
surface area of the control and Biofield Energy Treated zinc 
chloride were investigated and the results are presented in the 
Table 2. It was evident that the Biofield Energy Treatment 
has the ability to reduce the particle size (d10, d50, and d90) of 
zinc chloride with respect to the control sample. The size of 
the particles at below 10% level (d10), 50% level (d50), and 
90% level (d90) were decreased by 3.70%, 4.13%, and 6.13%, 
respectively in the Biofield Energy Treated sample compared 
to the control sample.  
Table 2. Particle size data (d10, d50, and d90) and surface area of the control and Biofield Energy Treated zinc chloride. 
Parameter d10 (µm) d50 (µm) d90 (µm) Surface area (m
2/g) 
Control 0.973 2.591 6.023 3.09 
Biofield Energy Treated 0.937 2.484 5.654 3.22 
Percent change (%)* -3.70 -4.13 -6.13 4.21 
*denotes the percentage change in the particle size data (d10, d50, and d90) and surface area of the Biofield Energy Treated sample with respect to the control 
sample. 
The particle size and surface area have a major effect on 
dissolution of a compound in a solvent, because the surface 
energy influenced by the surface area and chemical affinity is 
the driving factor for dissolution efficiency [48, 49]. The 
surface area for both the control and Biofield Energy Treated 
zinc chloride samples were analyzed and the results are 
presented in Table 2. The control sample showed surface area 
of 3.09 m2/g and it was increased to 3.22 m2/g in the Biofield 
Energy Treated zinc chloride. The surface area of the 
Biofield Energy Treated sample increased by 4.21% 
compared with the control sample.  
Poorly crystallized compounds possess more surface area 
and higher exchange capacities than well-crystallized 
compounds [50]. In addition, the variation of the crystal 
morphology in the Biofield Energy Treated sample, which 
was well-supported from PXRD data, may cause to alter the 
surface area of the Biofield Energy Treated zinc chloride 
compared with the control sample. It has been well 
established that the particle size, shape and surface area of 
pharmaceutical compounds have an important impact on 
solubility, dissolution and in vivo bioavailability, as well as 
supports the designing of new drug delivery systems [51, 52]. 
Reducing the particle size and higher surface area would 
enhance the solubility of the solid particles, and consequently 
would increase the dissolution rate and bioavailability [53]. 
Thus, it is assumed that the Biofield Energy Treated zinc 
chloride might be dissolved and absorbed at a faster rate and 
may possibly have more bioavailability than untreated zinc 
chloride. 
 American Journal of Bioscience and Bioengineering 2017; 5(2): 65-74  70 
 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of the control and Biofield Energy 
Treated samples of zinc chloride are presented in the Figure 2. 
The characteristic peaks were observed at 3904, 3583, 3518, 
1931, 1609, 986, and 512 cm-1 in the control FT-IR spectrum 
(Figure 2). On the other hand, the FT-IR spectrum of the 
Biofield Energy Treated zinc chloride showed the notable 
absorption bands at 3905, 3583, 3519, 1931, 1608, 985, and 
520 cm-1 (Figure 2). The strong and broad absorption band 
centered near 3583 cm-1 and the H-O-H bending motion at 
1608 cm-1 that were due to the presence of the lattice water 
were found in the FT-IR spectrum of both the control and 
Biofield Energy Treated samples (Figure 2). Literature 
suggested that the metal-halide stretching absorption band for 
inorganic materials generally found in the 750-100 cm-1 region 
[54]. In control spectrum, metal-halogen (Zn-Cl) stretching 
was found at 512 cm-1, whereas it was shifted upward in the 
Biofield Energy Treated sample at 520 cm-1. Overall, FT-IR 
results suggest that there may be a significant impact of 
Biofield Energy Treatment on zinc chloride at the atomic level 
to increase the force constant of Zn-Cl bonds. This result also 
supported with the PXRD data that Biofield Energy Treated 
sample might be new polymorphic form of zinc chloride. 
 
Figure 2. FT-IR spectra of the control and Biofield Energy Treated zinc chloride. 
3.4. Ultraviolet-Visible Spectroscopy (UV-Vis) Analysis 
The UV-visible spectra of both the control and Biofield 
Energy Treated zinc chloride are presented in the Figure 3. 
The spectra of control and Biofield Energy Treated sample 
showed the maximum absorbance (λmax) at 197.6 nm and 
197.1 nm, respectively, along with similar shift of 
absorbance maxima from 1.4723 in control and 1.4727 in 
Biofield Energy Treated sample. The UV absorbance occurs 
due to the diverse type of energy transitions from the singlet 
to the singlet excited state such as σ → σ∗,  n → π∗,  and 
 π → π∗.  These type of electronic transitions are occurred 
when the difference in energy between the lowest unoccupied 
molecular orbital (LUMO) and the highest occupied 
molecular orbital (HOMO) is significantly higher than the 
activation energy of the compound [55]. The UV-vis 
spectroscopic analysis of zinc chloride displayed no change 
in the λmax of the Biofield Energy Treated sample compared 
to the control sample. Thus, the structural configuration or 
activation energy of the Biofield Energy Treated sample was 
not changed compared with the control sample. 
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Figure 3. UV-Vis spectra of the control and Biofield Energy Treated zinc chloride. 
3.5. Differential Scanning Calorimetry (DSC) Analysis 
The DSC thermograms of the control and Biofield Energy 
Treated zinc chloride are presented in the Figure 4. The 
melting/decomposition temperature and enthalpy of 
fusion/decomposition of the control and Biofield Energy 
Treated zinc chloride are presented in the Table 3. The 
melting/fusion temperature was slightly decreased by 0.22% 
in the Biofield Energy Treated zinc chloride (311.01°C) 
compared with the control sample (311.71°C). The onset 
melting temperature was increased by 1.47% and the endset 
temperature was decreased slightly by 0.26% in the Biofield 
Energy Treated sample compared with the control sample. 
The latent heat of fusion or enthalpy of fusion (∆Hfusion) of 
the control and Biofield Energy Treated zinc chloride was 
384.67 J/g and 320.44 J/g, respectively. The ∆Hfusion of the 
Biofield Energy Treated sample was significantly decreased 
by 16.70% compared with the control sample. Similarly, the 
decomposition temperature of the Biofield Energy Treated 
zinc chloride (384.29°C) was increased by 2.56% compared 
to the control sample (392.59C). The onset and endset 
decomposition temperature was increased by 1.95% and 
2.83% in the Biofield Energy Treated sample compared with 
the control sample. The enthalpy of decomposition 
(∆Hdecomposition) of the control and Biofield Energy Treated 
zinc chloride were 427.90 J/g and 952.53 J/g, respectively. 
The ∆Hdecomposition of the Biofield Energy Treated sample was 
significantly increased by 122.61% compared with the 
control sample. Overall, results indicated that the zinc 
chloride need more energy in the form of latent heat to 
undergo the process of decomposition after Biofield Energy 
Treatment. It is anticipated that Biofield Energy Treatment 
might enhance the internal energy in zinc chloride that leads 
to increase of the decomposition temperature and the 
enthalpy of decomposition and ultimately to enhance the 
overall thermal stability of the Biofield Energy Treated 
sample significantly compared with the untreated sample. 
The enhanced thermal stability of a drug is an advantage in 
the maintenance of the product in long term storage condition 
throughout the shelf-life for any pharmaceutical formulations 
[56]. 
Table 3. The latent heat of fusion (J/g), enthalpy of decomposition (J/g) and 
melting/decomposition temperature (°C) values of the control and Biofield 
Energy Treated zinc chloride. 
Endothermic 
peak 
Description 
Tonset 
(°C) 
Tpeak 
(°C) 
Tendset 
(°C)  
∆H 
(J/g) 
Endothermic 
peak 
Control sample 298.96 311.71 316.68 384.67 
Biofield Energy 
Treated sample 
303.34 311.01 315.87 320.44 
% Change* 1.47 -0.22 -0.26 -16.70 
Exothermic 
peak 
Control sample 381.03 384.29 385.16 427.90 
Biofield Energy 
Treated sample 
388.47 392.59 396.05 952.53 
% Change* 1.95 2.56 2.83 122.61 
Tonset: Onset melting/decomposition temperature, Tpeak: Peak 
melting/decomposition temperature, Tendset: Endset melting/decomposition 
temperature, ∆H: Enthalpy of fusion/decomposition, *denotes the percentage 
change of the Biofield Energy Treated sample with respect to the control 
sample. 
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Figure 4. DSC thermograms of the control and Biofield Energy Treated zinc chloride. 
4. Conclusions 
The current study revealed that The Trivedi Effect® - 
Energy of Consciousness Healing Treatment had the 
significant effects on the physical, structural, thermal, and 
behavioral properties of zinc chloride. The PXRD data 
displayed the significant alteration of the crystallite size and 
relative intensities of the PXRD peaks in The Trivedi Effect® 
treated sample compared with the control sample. The 
average crystallite size of the treated sample was 
significantly increased by 23.18% compared with the control 
sample. The particle size values at d10, d50, and d90 were 
significantly decreased by 3.70%, 4.13%, and 6.13%, 
respectively in the treated sample compared with the control 
sample. Therefore, the surface area of the treated sample was 
increased by 4.21% compared with the control sample. The 
FT-IR spectroscopic analysis revealed that Zn-Cl stretching 
in the control sample was 512 cm-1, whereas it was 
significantly shifted upward to 520 cm-1 in the treated 
sample. The DSC analysis exhibited that the melting 
temperature was decreased by 0.22%, while decomposition 
temperature was increased by 2.56% in the treated sample 
compared to the control sample. The latent heat of fusion of 
the treated sample was significantly decreased by 16.70% 
compared with the control sample. Similarly, the enthalpy of 
decomposition of the treated sample was significantly 
increased by 122.61% compared with the control sample. 
The results indicated that the thermal stability of the treated 
zinc chloride was improved compared with the control 
sample. Thus, the treated sample could be more stable during 
manufacturing, delivery or storage conditions than the 
untreated sample. Briefly, The Trivedi Effect® - Energy of 
Consciousness Healing Treatment might introduce a new 
thermally stable polymorphic form of zinc chloride that could 
be more soluble and bioavailable compared with the 
untreated compound. Hence, Biofield Energy Treated zinc 
chloride would be very useful to design better nutraceutical 
and/or pharmaceutical formulations that might offer better 
therapeutic response against inflammatory diseases, 
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Properties of the Energy of Consciousness Healing Treated Zinc Chloride 
immunological disorders, aging, stress, cancer, Wilson’s 
disease, viral diseases, parakeratosis, hypogeusia, anorexia, 
dysosmia, geophagia, hypogonadism, growth retardation, etc. 
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